Infectious Disease and Microbiology: Gingivitis




Gingivitis is an inflammation of the gingiva that commonly presents with localized bleeding, especially during brushing, and may progress to more serious periodontal disease if untreated. It can be classified into dental plaque–induced and non–plaque-induced types, with plaque-induced gingivitis being the most frequent form. In severe cases, it may lead to systemic symptoms such as fever or even tooth loss secondary to progression into periodontitis.


Epidemiologically, gingivitis is highly prevalent, particularly among adults over 35 years of age. Its incidence is increased in individuals with immunodeficiency and during pregnancy. Several risk factors contribute to its development, including poor dental hygiene, systemic diseases such as diabetes mellitus and coronary artery disease, malocclusion, malnutrition, and infections like HIV. Certain medications, including oral contraceptive pills and Phenytoin, are also associated with an increased risk.


The pathophysiology involves both acute and chronic inflammation of the gingiva due to accumulation of bacterial plaque at the gingival margin. This leads to hyperemia, infiltration of neutrophils, and bacterial proliferation. The most common causative organisms include Streptococcus species, actinomycetes, spirochetes, and various anaerobic bacteria. Persistent inflammation can eventually damage the supporting structures of the teeth.


Clinically, gingivitis often begins with bleeding gums during brushing, which is usually the earliest symptom. Patients may also report halitosis. On physical examination, the gingiva appears erythematous, edematous, and may bleed easily, with visible plaque and calculus. In advanced cases, the tissue may become necrotic, and a severe form known as Vincent’s angina may develop, characterized by pain, swelling, fever, and lymphadenopathy.


Diagnosis of gingivitis is primarily clinical, based on history and physical findings. Laboratory investigations are generally not required. It is important to differentiate gingivitis from other oral conditions such as periodontitis, glossitis, and pericoronitis. Close follow-up with a dental provider is essential to monitor progression and ensure adequate management.


Treatment focuses on removal of dental plaque and improvement of oral hygiene. Professional debridement and use of antimicrobial mouth rinses such as chlorhexidine are first-line measures. In severe cases, antibiotics targeting oral flora, including Metronidazole, penicillins, or clindamycin, may be required. Additional measures include elimination of local irritants, smoking cessation, and regular dental checkups.


The prognosis of gingivitis is excellent with appropriate treatment and adherence to good oral hygiene practices. However, recurrence is common if preventive measures are not maintained. Potential complications include progression to severe periodontal disease, tooth loss, gingival or bone abscess formation, and possible associations with systemic conditions such as coronary artery disease.

​

Infectious Disease and Microbiology: Giardiasis




Giardiasis is a parasitic infection of the upper small intestine caused by Giardia lamblia (also known as Giardia intestinalis). It is one of the most common causes of protozoal diarrhea worldwide and is transmitted primarily via the fecal–oral route. Infection occurs through ingestion of cysts in contaminated water, food, or through direct person-to-person contact. Although many infections are asymptomatic, symptomatic cases can lead to prolonged gastrointestinal illness.


Epidemiologically, giardiasis has a global distribution and is especially common in areas with poor sanitation. It is responsible for thousands of cases annually, including approximately 20,000 cases per year in the United States. Outbreaks are often linked to contaminated water supplies, while sporadic cases commonly occur through direct transmission in settings such as daycare centers, institutions, and among individuals with close contact. Travelers to endemic regions, particularly in parts of Asia, are at increased risk.


The pathophysiology begins with ingestion of infective cysts, which are resistant and can survive in water for extended periods. Once ingested, the cysts undergo excystation in the upper gastrointestinal tract, releasing trophozoites that attach to the mucosa of the duodenum and jejunum. These organisms disrupt the intestinal brush border, leading to malabsorption and diarrhea. The infection does not typically invade tissues but causes functional impairment of absorption.


Clinically, giardiasis may be asymptomatic or present after an incubation period of about 1–3 weeks. The hallmark symptom is diarrhea, which is often subacute and may persist for weeks or months if untreated. Stools are typically pale, bulky, foul-smelling, and greasy due to fat malabsorption (steatorrhea). Other symptoms include abdominal cramps, bloating, excessive gas, weight loss, anorexia, and occasionally nausea or vomiting. Blood and mucus are usually absent, and systemic symptoms are mild. Chronic infection may occur, especially in immunocompromised individuals.


Diagnosis is primarily made by identifying cysts or trophozoites in stool samples through microscopy. Multiple stool examinations increase diagnostic yield. Antigen detection tests using ELISA or immunofluorescence are highly sensitive and specific and are commonly used. In rare or difficult cases, duodenal sampling may be required. Histological examination may show villous atrophy and mild inflammation.


Treatment is indicated for symptomatic patients and to prevent transmission in asymptomatic carriers, particularly children. First-line therapy includes Metronidazole, Tinidazole, or Nitazoxanide, all of which are highly effective. Alternative treatments include albendazole or quinacrine in resistant cases. Patients should avoid alcohol while taking metronidazole due to adverse reactions. Persistent or recurrent infection may require retreatment or evaluation of close contacts.


The prognosis of giardiasis is generally good, with most cases resolving either spontaneously or with treatment. However, untreated infection may lead to chronic diarrhea, malabsorption, steatorrhea, and weight loss. Complications can include lactose intolerance and nutritional deficiencies. Preventive measures such as proper sanitation, boiling or filtering drinking water, and good personal hygiene are essential in reducing transmission.

​

​Infectious Disease and Microbiology: Genital Herpes


Genital herpes is a common sexually transmitted infection caused by the Herpes Simplex Virus, characterized by painful vesicular lesions on the genitalia. It is most frequently caused by HSV-2, although HSV-1 is increasingly responsible for genital infections. The disease is marked by recurrent episodes due to the virus’s ability to establish lifelong latency in sensory nerve ganglia, with periodic reactivation leading to symptomatic or asymptomatic viral shedding.


Epidemiologically, genital herpes is highly prevalent, with tens of millions of individuals affected worldwide. In the United States alone, at least 50 million people are infected. HSV-2 seroprevalence has slightly declined over time, while genital HSV-1 infections appear to be increasing. Higher prevalence is observed among individuals of lower socioeconomic status and certain populations, reflecting differences in sexual networks. Women are at greater risk of acquiring HSV-2 infection compared to men.


Transmission occurs primarily through sexual contact with an infected individual, including during asymptomatic viral shedding, which is more common in HSV-2 infection. Risk factors include unprotected sexual intercourse and having multiple sexual partners. Preventive strategies include consistent condom use, abstinence during active lesions or prodromal symptoms, and suppressive antiviral therapy in individuals with frequent recurrences. Suppressive treatment with antiviral agents such as Valacyclovir has been shown to reduce transmission risk.


The clinical presentation varies between primary and recurrent infections. The incubation period is typically 2–7 days. Primary infection is usually more severe and may last up to three weeks, presenting with painful vesicles that rupture into ulcers, along with systemic symptoms such as fever, headache, malaise, and myalgias. Recurrent episodes are generally milder and shorter in duration and are often preceded by prodromal symptoms such as tingling, burning, or pain at the site of recurrence. Over time, the frequency and severity of recurrences tend to decrease.


On physical examination, patients typically have multiple small vesicles on an erythematous base that progress to painful ulcers. In women, lesions commonly involve the vulva, vaginal vestibule, and cervix, while in men, lesions are found on the penis, scrotum, or surrounding areas. Tender regional lymphadenopathy is common. Complications such as urethritis, cervicitis, or proctitis may occur depending on the site of infection.


Diagnosis is confirmed through laboratory testing, as clinical diagnosis alone may be inaccurate. Polymerase chain reaction (PCR) testing for HSV DNA is the most sensitive method and can distinguish between HSV-1 and HSV-2. Viral culture and serologic testing for HSV antibodies may also be used, although culture has lower sensitivity, especially in recurrent lesions.


Management involves antiviral therapy to reduce symptom severity and duration. First-line treatments include Acyclovir, Valacyclovir, and Famciclovir. For primary infection, treatment is typically given for 7–10 days, while recurrent episodes may be treated episodically or with long-term suppressive therapy in patients with frequent recurrences. Severe or disseminated infections may require intravenous antiviral therapy.


The prognosis is generally good in immunocompetent individuals, although the infection is lifelong with potential for recurrence. Complications include secondary infections, aseptic meningitis, and increased susceptibility to HIV transmission. Neonatal herpes, acquired during childbirth, is a serious condition with high mortality if untreated. Patient education is essential and should emphasize the chronic nature of the disease, risk of transmission even without symptoms, and the importance of preventive measures.

Infectious Disease and Microbiology: Gas Gangrene




Gas gangrene is a severe, life-threatening infection of muscle and soft tissue caused by toxin- and gas-producing bacteria of the genus Clostridium, most commonly Clostridium perfringens. It is characterized by rapidly progressive muscle necrosis, severe pain, gas formation within tissues, and systemic toxicity that can lead to sepsis and death. The disease typically develops within 1–4 days after trauma, although longer incubation periods may occur. Historically, it has been strongly associated with wartime injuries, but it can also arise following minor trauma, surgery, or even spontaneously.


Epidemiologically, trauma accounts for approximately half of all cases, with an estimated 1,000–3,000 cases occurring annually in the United States. The condition is more common in men and typically affects individuals aged 35–40 years. Risk factors include conditions that impair blood supply or immune response, such as diabetes mellitus, peripheral vascular disease, atherosclerosis, chronic alcoholism, malnutrition, HIV/AIDS, corticosteroid use, and intravenous drug use. Open wounds, burns, and surgical procedures also increase susceptibility.


The pathophysiology of gas gangrene is closely related to the anaerobic environment created by compromised blood supply in damaged tissues, which allows clostridial spores to germinate and proliferate. The bacteria produce multiple toxins, most notably alpha-toxin, which has phospholipase activity that destroys cell membranes. This leads to widespread destruction of red blood cells, white blood cells, platelets, and muscle tissue, resulting in necrosis, hemolysis, and shock. Other toxins, such as collagenases, further damage blood vessels and surrounding tissues, facilitating rapid spread of infection.


Clinically, the disease often begins with sudden, severe pain at the site of injury, which is disproportionate to physical findings. Early signs may include swelling and tenderness, followed by skin discoloration that progresses to violaceous changes and the formation of bullae containing foul-smelling discharge. Crepitus due to gas formation may be palpable. Systemic signs range from mild fever and tachycardia to severe septic shock. Hemolysis may cause jaundice and dark urine, while patients may remain conscious despite profound hypotension in early stages.


Diagnosis is primarily clinical but supported by laboratory and imaging findings. Laboratory tests may reveal anemia, hemolysis, electrolyte disturbances, renal dysfunction, and metabolic acidosis. Gram stain of wound exudate typically shows large gram-positive rods. Imaging studies such as X-rays, ultrasound, CT, or MRI can demonstrate gas within soft tissues. Definitive diagnosis may be confirmed by tissue biopsy and culture, with surgical exploration revealing pale, non-contractile necrotic muscle.


Treatment is an emergency and requires immediate, aggressive intervention. The cornerstone of management is prompt surgical debridement of all necrotic tissue, which is the most critical life-saving measure. This is combined with high-dose intravenous antibiotics, typically clindamycin and penicillin. Supportive care includes aggressive fluid resuscitation, management of shock, and correction of metabolic abnormalities. Hyperbaric oxygen therapy may be used as an adjunct, although it should never delay surgery.


The prognosis depends on the speed of diagnosis and treatment. Early intervention significantly reduces mortality, whereas delayed treatment is associated with high rates of complications and death. Outcomes are worse in patients with spontaneous gas gangrene or significant comorbidities. Complications include hemolysis, disseminated intravascular coagulation, acute renal failure, acute respiratory distress syndrome, shock, and death. Survivors may require amputation or experience permanent disability, highlighting the importance of early recognition and urgent management.

​

Emergency and Acute Medicine – Tinea Infections (Cutaneous)




Cutaneous tinea infections are superficial fungal infections involving the hair, skin, or nails, typically confined to the stratum corneum. They are among the most common diseases worldwide and require keratin for growth, which explains why mucosal surfaces are not affected. These infections are named according to their anatomical location. The causative organisms are dermatophytes, primarily species of Microsporum, Trichophyton, and Epidermophyton. In contrast, tinea versicolor is caused by Malassezia furfur, a yeast, and is not a true dermatophyte infection. Transmission may occur via direct contact with infected individuals, animals, or contaminated soil, and skin trauma or maceration facilitates fungal entry. In children, spread can occur through shared items such as toys or brushes, while nail infections are uncommon unless associated with conditions like immunosuppression or Down syndrome.


Clinical presentation varies depending on the site of infection but is generally characterized by itching as the main symptom. Tinea capitis primarily affects children and presents with scalp involvement, including alopecia, scaling, and characteristic “black dots” from broken hairs. Inflammatory forms such as kerion may appear as boggy, purulent masses with associated lymphadenopathy. Tinea corporis, or ringworm, presents as annular lesions with raised, well-demarcated borders and central clearing, commonly affecting the trunk and extremities. Tinea cruris involves the groin, thighs, and buttocks, producing erythematous, scaly patches that typically spare the scrotum and penis, helping differentiate it from candidiasis. Tinea pedis, the most common form in adults, manifests as scaling, maceration, and fissuring between the toes, often associated with moisture and poor foot hygiene. Tinea unguium (onychomycosis) causes thickened, discolored nails with subungual debris and nail separation. Tinea versicolor presents with hypo- or hyperpigmented macules on the upper trunk, arms, and neck, especially in warm climates.


Diagnosis is primarily clinical, based on history and physical examination. If uncertainty exists, confirmation can be achieved through microscopy using potassium hydroxide (KOH) preparation, which demonstrates fungal elements such as septate hyphae in dermatophyte infections or the characteristic “spaghetti and meatballs” pattern in Malassezia. Fungal cultures are generally not necessary due to slow growth. Wood lamp examination has limited utility, as most dermatophytes do not fluoresce, although Microsporum species may appear green and Malassezia yellow-green.


Treatment depends on the site and severity of infection. Most superficial infections such as tinea corporis, cruris, and pedis respond well to topical antifungals, including terbinafine or imidazoles like clotrimazole and miconazole. Keeping the affected area dry and maintaining hygiene are important adjuncts. In contrast, infections involving hair or nails, such as tinea capitis and tinea unguium, require systemic therapy because topical agents do not adequately penetrate these structures. Oral terbinafine is commonly used and is considered first-line for tinea capitis, while longer treatment durations are required for nail infections. Selenium sulfide or ketoconazole shampoos may reduce transmission in scalp infections. Tinea versicolor is typically treated with topical agents such as selenium sulfide shampoo or topical azoles, with oral therapy reserved for extensive or refractory cases.


Most patients improve within 1–2 weeks of treatment, although hair and nail infections require prolonged therapy lasting several months. Patients can usually be managed as outpatients, with hospital admission reserved for rare cases of invasive infection in immunocompromised individuals or complicated kerion with secondary bacterial infection. Follow-up is important for patients on oral antifungal therapy to monitor for adverse effects, particularly hepatotoxicity.


Key clinical pearls include recognizing tinea capitis as the most common dermatophyte infection in children and understanding that itching is the predominant symptom across most forms. Tinea pedis can predispose to cellulitis, and recurrence of infections, particularly in the feet and groin, is common. Preventive measures such as proper hygiene and avoiding sharing personal items are essential to reduce reinfection and transmission.

​

Emergency and Acute Medicine – Tick Bite




Tick bites are a common presentation, but the actual risk of acquiring a tick-borne infection is low, even in endemic areas. Most patients seek care because of concern about Lyme disease, proper tick removal, or local skin reactions rather than true systemic illness.


Ticks belong to two main groups: soft ticks (such as Ornithodoros), which feed briefly and are rarely noticed, and hard ticks (especially Ixodes and Dermacentor), which feed for several days and are more clinically relevant. Lyme disease is most commonly transmitted by the nymph stage of Ixodes scapularis (deer tick). Transmission generally requires prolonged attachment, typically 24–48 hours, and the degree of tick engorgement serves as an important indicator of duration and risk.


Clinically, patients usually present with a visible tick attached to the skin and are often otherwise asymptomatic. There may be mild local irritation, redness, or swelling. Patient anxiety about infection is very common. However, red flags include fever after a tick bite, neurologic symptoms (particularly in children, where tick paralysis must be considered), or signs of systemic illness such as hypotension or sepsis, which may suggest serious infections like Rocky Mountain spotted fever, anaplasmosis, or babesiosis. Because early diagnostic tests are often not helpful, these conditions are largely diagnosed based on clinical presentation and epidemiologic context.


Routine laboratory testing is not indicated for simple tick bites. Lyme serology is not useful immediately after a bite because it reflects prior exposure rather than acute infection, and testing the tick itself is not recommended. Management therefore focuses primarily on proper tick removal and clinical observation.


The most important step in management is early and proper removal of the tick. This is done using fine forceps, grasping the tick as close to the skin as possible, and applying slow, steady upward traction over 30–120 seconds. The tick should not be squeezed, twisted, burned, or covered with substances such as petroleum jelly, as these methods may increase the risk of pathogen transmission. If mouthparts remain embedded in the skin, they may cause local irritation or a foreign body reaction but do not increase the risk of systemic infection.


Antibiotic prophylaxis for Lyme disease is only indicated in specific circumstances. These include identification of an engorged Ixodes scapularis tick, likely attachment for at least 24–48 hours, and removal within 72 hours. In such cases, a single dose of doxycycline 200 mg is recommended. In children, a single-dose regimen is not well studied, and amoxicillin for 10 days may be used instead. There is no evidence to support prophylactic antibiotics for other tick-borne diseases.


Supportive care consists of wound cleaning, reassurance, and education. Most patients can be safely discharged after tick removal. Admission is reserved for those with signs of systemic illness, tick paralysis, or severe tick-borne infection.


Patients should be advised to seek medical attention if they develop fever, rash (particularly an expanding rash suggestive of erythema migrans), joint pain, or neurologic symptoms. Preventive counseling is important and includes the use of insect repellents such as DEET and wearing permethrin-treated clothing in endemic areas.


Key clinical pearls include the importance of early tick removal in reducing infection risk and the selective—not routine—use of antibiotic prophylaxis. Clinicians should always inquire about tick exposure in febrile patients. In children presenting with unexplained weakness, especially girls with long hair, careful scalp examination is essential to rule out tick paralysis.

​

Infectious Disease and Microbiology: Fungal Infections of the Hair, Skin, and Nails (Dermatophytosis / Tinea)




Fungal infections of the hair, skin, and nails—collectively known as dermatophytosis or tinea—are common infectious diseases affecting keratinized tissues. These infections are caused by dermatophyte fungi that invade the superficial layers of the skin, hair, or nails through enzymes such as keratinases. They are classified based on the site of infection, including tinea pedis (feet), tinea corporis (body), tinea cruris (groin), tinea capitis (scalp), and onychomycosis (nails). These infections occur worldwide and are particularly common in hot and humid climates.


Epidemiologically, dermatophytosis affects different populations depending on the type. Tinea capitis is most common in children, while tinea pedis is more frequently seen in young adult males. Onychomycosis is the most common nail disorder in adults. Risk factors include excessive moisture, tight clothing, poor hygiene, diabetes mellitus, obesity, and immunosuppression. Transmission occurs through direct contact with infected individuals, animals, or contaminated objects such as towels, footwear, and communal shower surfaces.


The pathophysiology involves fungal invasion of keratinized structures such as the stratum corneum, hair shafts, and nail beds. The fungi proliferate outward, producing characteristic ring-shaped lesions with central clearing in skin infections. In scalp infections, the hair becomes brittle and breaks, resulting in patches of alopecia. Nail infections lead to thickened, discolored, and brittle nails. The host immune response contributes to inflammation, scaling, and itching, while also attempting to contain the infection.


Clinically, the presentation varies according to the site involved. Tinea pedis typically presents with itching, scaling, and fissuring between the toes. Tinea corporis manifests as circular, erythematous, scaly lesions with raised borders. Tinea cruris causes an itchy rash in the groin area. Tinea capitis presents with scalp scaling, hair loss, and sometimes pustules. Onychomycosis results in thickened, discolored, and brittle nails. Secondary bacterial infection may complicate some cases, especially in tinea pedis.


Diagnosis is usually established by microscopic examination of skin scrapings, hair, or nail samples using potassium hydroxide preparation. Fungal cultures on specialized media can confirm the diagnosis, and Wood’s lamp examination may assist in detecting certain species. Advanced techniques such as polymerase chain reaction may be used in specialized settings.


Treatment depends on the severity and location of the infection. Most superficial infections respond to topical antifungal agents such as Terbinafine, tolnaftate, or undecylenic acid. Oral antifungal therapy, including Griseofulvin or Ketoconazole, is required for more extensive disease, scalp involvement, or nail infections. Onychomycosis typically requires prolonged treatment. Preventive measures such as maintaining hygiene, keeping skin dry, avoiding sharing personal items, and using protective footwear in communal areas are important to prevent recurrence.


The prognosis is generally excellent with appropriate treatment, although recurrence is common if predisposing factors persist. Complications are uncommon but may include secondary bacterial infections, chronic disease, and, in severe scalp infections, permanent hair loss. Early diagnosis and adherence to therapy are essential for successful management.

​

Infectious Disease And Microbiology – Food-Borne Diseases




Food-borne diseases are illnesses that result from ingestion of food contaminated by pathogenic microorganisms, microbial toxins, or chemical substances. They are extremely common and represent a major public health problem. In the United States alone, it has been estimated that more than 75 million episodes occur annually. Outbreaks are most often caused by noroviruses, followed by Salmonella. Infants, older adults, and immunocompromised individuals are at particularly high risk for severe disease. Some pathogens also have specific risk groups; for example, Vibrio vulnificus infection is more common and more severe in patients with chronic liver disease or other forms of immunosuppression.


Prevention is centered on safe food handling and avoidance of high-risk foods. Raw or undercooked eggs, unpasteurized dairy products, raw or undercooked meat, poultry, and seafood, as well as soft cheeses, should be avoided when possible. Cross-contamination during food preparation should be prevented, and handwashing before handling food is essential. Vaccination also plays a role in prevention, particularly hepatitis A immunization and infant vaccination against rotavirus.


The causes of food-borne illness are broad and include bacterial, viral, parasitic, and noninfectious toxins. Bacterial causes include Salmonella, Shigella, enterohemorrhagic and enterotoxigenic Escherichia coli, Campylobacter jejuni, Vibrio species, Yersinia species, Clostridium perfringens, Staphylococcus aureus, Bacillus cereus, Clostridium botulinum, and Listeria monocytogenes. These organisms are associated with particular foods such as poultry, eggs, shellfish, contaminated water, undercooked beef, rice, canned foods, and unpasteurized dairy products. Viral agents include norovirus, rotavirus, and hepatitis A virus, while parasites include Giardia lamblia, Entamoeba histolytica, Cryptosporidium, and Cyclospora cayetanensis. Noninfectious causes include marine toxins such as ciguatera toxin, scombroid toxin, tetrodotoxin, shellfish toxins, as well as heavy metals, mushroom toxins, pesticides, and certain food additives such as monosodium glutamate.


The clinical presentation depends on the causative agent. Bacterial infections often present with diarrhea, abdominal cramps, fever, nausea, and vomiting, although the exact pattern varies. Salmonella commonly causes diarrhea, fever, and cramps, while Shigella often produces bloody, mucus-containing stools. Enterohemorrhagic E. coli typically causes severe abdominal pain and bloody diarrhea with little or no fever. Campylobacter may cause bloody diarrhea and fever, while cholera presents with profuse watery diarrhea leading to dehydration. Preformed toxin illnesses such as those caused by Staphylococcus aureus and the emetic type of Bacillus cereus produce abrupt, intense vomiting within hours of ingestion. Clostridium botulinum causes gastrointestinal symptoms followed by neurologic signs such as blurred vision, diplopia, dysphagia, and descending paralysis.


Viral food-borne diseases commonly cause acute gastroenteritis. Norovirus produces nausea, vomiting, cramping, diarrhea, low-grade fever, and myalgias, with vomiting more common in children and diarrhea more common in adults. Rotavirus causes vomiting and watery diarrhea, especially in young children. Hepatitis A has a much longer incubation period and presents with jaundice, dark urine, flu-like symptoms, and sometimes diarrhea.


Parasitic infections tend to have more prolonged courses. Giardia causes diarrhea, gas, and abdominal cramps that may last weeks to months. Entamoeba histolytica often causes bloody diarrhea and lower abdominal pain. Cryptosporidium usually causes watery diarrhea and cramps, while Cyclospora often causes prolonged watery diarrhea with nausea, anorexia, and weight loss.


Noninfectious food-borne toxins often produce rapid symptom onset. Ciguatera poisoning causes gastrointestinal symptoms followed by neurologic manifestations such as paresthesias and reversal of hot and cold sensation, and sometimes cardiovascular effects such as bradycardia and hypotension. Scombroid poisoning causes flushing, rash, urticaria, dizziness, and paresthesias shortly after eating affected fish. Tetrodotoxin from puffer fish causes rapid neurologic symptoms, ascending paralysis, and respiratory failure. Shellfish toxins may cause diarrheal, neurotoxic, amnesic, or paralytic syndromes depending on the toxin involved.


Physical examination usually focuses on assessing dehydration and abdominal findings. Signs such as dry mucous membranes, reduced urine output, tachycardia, and hypotension suggest volume depletion. Abdominal tenderness may be present. In Vibrio vulnificus infection, bullous skin lesions may occur.


Diagnosis depends on the suspected cause. Stool culture is useful for Salmonella, Shigella, Campylobacter, certain E. coli strains, Vibrio, and Yersinia, although special media are needed for some of these organisms. Clostridium botulinum diagnosis relies on testing stool, serum, or food for toxin. Viral illnesses such as norovirus are often diagnosed clinically, while rotavirus can be identified by stool immunoassay and hepatitis A by positive IgM antibody. Parasitic infections are diagnosed by stool examination for ova, cysts, or parasites, or by enzyme immunoassays. Toxin-mediated illnesses may require toxin assays, chromatography, or histamine detection in food.


Treatment for most food-borne illnesses is supportive, with fluid and electrolyte replacement as the mainstay. Specific antimicrobial therapy is reserved for selected infections. Typhoid fever caused by Salmonella typhi or S. paratyphi may be treated with cefixime, ceftriaxone, or quinolones, although resistance is an issue in some regions. Severe enterotoxigenic E. coli and Campylobacter infections may be treated with antibiotics. Cholera requires aggressive rehydration plus doxycycline or tetracycline in adults, or trimethoprim-sulfamethoxazole in young children. Botulism requires prompt antitoxin administration, with botulism immune globulin used in infants. Serious Listeria infections are treated with ampicillin, sometimes combined with gentamicin. Parasitic infections are treated with agents such as metronidazole, nitazoxanide, or trimethoprim-sulfamethoxazole depending on the organism. Noninfectious toxin syndromes are managed supportively, though antihistamines may help in scombroid poisoning and intravenous mannitol has been used for ciguatera.


The prognosis is generally good for most uncomplicated food-borne illnesses, though immunocompromised individuals may have prolonged disease and prolonged shedding of pathogens. Some conditions are life-threatening, especially cholera because of severe dehydration, and tetrodotoxin or paralytic shellfish toxin poisoning because of respiratory paralysis. Complications may also occur, such as temporary lactose intolerance after rotavirus infection, and reactive arthritis or Guillain–Barré syndrome after Campylobacter jejuni infection.

​

Infectious Disease And Microbiology – Filariasis




Filariasis is a tropical parasitic disease caused by thread-like nematode worms of the superfamily Filarioidea. These parasites are transmitted to humans by insect vectors and may live in the lymphatic system, skin, connective tissue, serous cavities, or blood vessels. Adult worms can survive in the human host for more than 20 years, causing chronic disease and disability.


Filariasis includes several distinct syndromes. Lymphatic filariasis, caused by Wuchereria bancrofti, Brugia malayi, and Brugia timori, is endemic in many tropical and subtropical regions of Asia, Africa, South and Central America, and the Pacific. More than one billion people are at risk worldwide, with over 120 million infected and tens of millions suffering from disabling disease. Loiasis is confined mainly to the rainforests of western and central Africa. Onchocerciasis, or river blindness, affects millions in Africa and parts of South America and is a major cause of blindness. Dracunculiasis, or Guinea worm disease, occurs mainly in parts of Africa and Yemen. Dirofilariasis is rare in humans but has worldwide distribution, while mansonelliasis occurs in Africa, the Caribbean, and parts of Central and South America.


Major risk factors include living in or traveling to endemic areas and low socioeconomic status. Prevention depends on health education, vector control, and avoidance of insect bites. Recommended measures include sleeping under mosquito nets, wearing long sleeves, and using insect repellents containing at least 30% DEET. For dracunculiasis, prevention also includes drinking clean or filtered water, preventing infected individuals from entering water sources, and treating contaminated water to kill copepods.


The pathophysiology differs by species. In lymphatic filariasis, adult worms damage lymphatic vessels, causing dilation, valvular dysfunction, lymphatic obstruction, and eventually irreversible lymphedema and elephantiasis. In loiasis, larvae introduced by fly bites migrate beneath the skin, causing transient localized swelling known as Calabar swellings. In onchocerciasis, adult worms form nodules in the skin while microfilariae migrate through skin and eyes, causing dermatitis and blindness. In dracunculiasis, ingested larvae mature and female worms migrate to the skin, typically in the lower limbs, where they emerge through painful ulcers. Dirofilariasis often causes localized granulomatous reactions or pulmonary nodules. In mansonelliasis, dying worms provoke inflammatory responses leading to abscesses or granulomas.


The causative organisms include Wuchereria bancrofti, Brugia species, Loa loa, Onchocerca volvulus, Dracunculus medinensis, Dirofilaria species, and Mansonella species. Each is transmitted by a specific vector, such as mosquitoes, blackflies, midges, red tabanid flies, or infected copepods in water.


The clinical manifestations depend on the species involved. Lymphatic filariasis may cause fever, lymphangitis, lymphadenitis, hydroceles, lymphedema, elephantiasis, epididymitis, and occasionally bronchospasm. Loiasis presents with transient swellings, itching, hives, and migration of the worm across the eye. Onchocerciasis causes subcutaneous nodules, severe itching, skin thickening or pigment changes, lymphadenopathy, and visual loss. Dracunculiasis presents with painful skin ulcers from which the worm emerges. Dirofilariasis may cause cough, chest pain, or hemoptysis. Mansonelliasis may cause fever, swelling, rash, itching, headaches, arthralgia, and neurologic symptoms.


Physical examination findings vary accordingly. In lymphatic filariasis, patients may have lymphadenopathy, hydroceles, enlarged spermatic cord, lower extremity lymphedema, or even arthritis. Loiasis often shows visible Calabar swellings or worms migrating beneath the conjunctiva. Onchocerciasis produces characteristic skin changes and nodules, along with ocular disease. Dracunculiasis reveals a visible white worm emerging from an ulcer, usually on the lower extremity. Mansonelliasis may show pruritus, rash, edema, fever, hepatomegaly, and neurologic signs.


Diagnosis depends on the specific infection. Blood smears may reveal microfilariae in lymphatic filariasis or mansonelliasis. Skin snips or biopsies are useful in loiasis and onchocerciasis. Dracunculiasis is usually diagnosed clinically. Histology may be needed for dirofilariasis. Ultrasound can show adult worms in lymphatic vessels, and imaging such as CT or MRI may detect pulmonary nodules or deep skin nodules. Plain radiographs may reveal calcified Guinea worms.


Treatment depends on the species. In lymphatic filariasis, doxycycline is used to target Wolbachia endosymbionts, followed later by albendazole and ivermectin. Loiasis is treated with diethylcarbamazine. Onchocerciasis is treated with ivermectin, repeated after six months, with prednisone used beforehand if the eyes are involved. Dracunculiasis requires slow mechanical extraction of the worm, sometimes aided by metronidazole or mebendazole. Mansonella species are treated with albendazole or ivermectin depending on the species involved. There is no effective medical therapy for dirofilariasis. In general, treatment is more effective against microfilariae than adult worms, so repeated therapy may be necessary.


Supportive care and specialist referral are often needed. Infectious disease consultation may be helpful, and ophthalmologic assessment is essential in onchocerciasis. Surgical treatment may be required for removal of nodules in onchocerciasis or lung lesions in dirofilariasis. Hospitalization is mainly needed for complications such as septicemia from open wounds.


With timely diagnosis and treatment, disability and disfigurement can often be limited. However, complications can be severe, especially in lymphatic filariasis, where elephantiasis and secondary bacterial infection may occur, and in onchocerciasis, where blindness is a major consequence.

​

​

Infectious Disease And Microbiology – Exanthem Subitum (Roseola Infantum)




Exanthem subitum, also known as roseola infantum or sixth disease, is a common, benign, self-limiting viral illness of early childhood. It is most often caused by human herpesvirus 6B (HHV-6B), although human herpesvirus 7 (HHV-7) may also be responsible.


Epidemiologically, the disease occurs worldwide and primarily affects children between 6 months and 3 years of age, with about 90% of cases occurring before age 2. By the age of 3, nearly all children have been exposed, with antibody prevalence approaching 100%. Maternal antibodies protect infants initially but decline by 6 months, after which susceptibility increases. HHV-7 tends to affect slightly older children and may be associated with a higher risk of febrile seizures.


Human herpesvirus 6B accounts for approximately 10–45% of febrile illnesses in young children. A small proportion of individuals (around 1%) are born with chromosomally integrated HHV-6, though the clinical significance remains unclear.


Currently, there are no specific preventive measures for primary infection. Prophylaxis may be considered in high-risk populations such as bone marrow transplant recipients.


Pathophysiologically, after primary infection, the virus establishes latency in various tissues including lymphoid organs, saliva, and the central nervous system. It infects multiple cell types such as CD4+ T lymphocytes, monocytes, macrophages, endothelial and epithelial cells, and astrocytes. Reactivation can occur, particularly in immunocompromised individuals.


Etiologically, HHV-6 exists as two variants, HHV-6A and HHV-6B, which are now considered distinct viruses. HHV-6 is closely related to cytomegalovirus (CMV). HHV-7 is another causative agent of roseola-like illness.


Clinically, the incubation period is approximately 10–14 days. In children, the disease typically presents with the abrupt onset of high fever (often up to 41°C), lasting 3–5 days. Despite the high fever, the child usually appears relatively well. As the fever subsides, a characteristic maculopapular rash appears in some cases (about 10%), beginning on the trunk and spreading to the face and limbs. The rash is pink, nonpruritic, transient, and resolves within 1–2 days without desquamation.


Associated symptoms may include mild upper respiratory features, cervical lymphadenopathy, and occasionally gastrointestinal symptoms such as diarrhea or vomiting. Febrile seizures occur in about 10% of cases. In infants, a bulging anterior fontanelle may be noted. In rare cases, especially in immunocompromised patients, complications such as encephalitis may occur.


In adults, primary infection or reactivation may present as a mononucleosis-like illness, upper respiratory infection, pneumonia, or hepatitis. In transplant patients, HHV-6 is an important cause of bone marrow suppression and interstitial pneumonitis.


On physical examination, key findings include high fever with abrupt resolution, followed by a transient rash, cervical lymphadenopathy, and generally preserved overall condition.


Laboratory findings may show leukopenia, lymphocytopenia, atypical lymphocytes, and sometimes mild hepatitis, especially in adults. The erythrocyte sedimentation rate is typically normal, and cerebrospinal fluid findings are usually normal unless there is CNS involvement. Diagnosis can be confirmed by PCR, viral isolation, or serology, although routine testing is not usually required in typical cases.


The differential diagnosis includes other viral infections such as CMV, adenovirus, measles, rubella, and viral upper respiratory infections, as well as serious bacterial infections. A key distinguishing feature is the child’s relatively well appearance despite high fever and the appearance of rash after defervescence.


Treatment is supportive in most cases. Antipyretics such as acetaminophen (paracetamol), adequate hydration, and comfort measures are usually sufficient. Antiviral therapy (e.g., ganciclovir or foscarnet) is reserved for severe cases or immunocompromised patients, particularly transplant recipients.


The prognosis is excellent, as the disease is self-limiting. Most children recover completely without complications.


Complications are rare but may include febrile seizures, and in immunocompromised patients, more severe outcomes such as pneumonia, hepatitis, bone marrow suppression, encephalitis, or aseptic meningitis.

​